Candida auris has emerged as a formidable global health threat due to its multi-drug resistance. As the incidence of Candida auris steadily increases and considering its difficulty to diagnose, treat and eradicate, the need for effective screening implementation is evident. Molecular methods, which are both sensitive and specific, would allow for an easy, low-cost and accurate way to identify Candida auris in a clinical setting.
For further information on all PCR kits available from PathoNostics, please contact info@serosep.com.
PathoNostic Kits are currently available in Ireland and the UK
